All Current Studies
If any of these studies interest you, please call us at 1-877-552-5837. (click study link for more details.)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Sequential Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
A Double-Blind, Placebo Controlled Study of Maca Root for the Treatment of Antidepressant-Induced Sexual Dysfunction in Females
A Double-Blind, Placebo Controlled Study of Maca Root for the Treatment of Sexual Dysfunction Associated with the Treatment Regimen for Bipolar Disorder in Females
A Randomized Controlled Study for the Treatment of Binge Drinking in College Students with Depressive Symptoms
A Study of Omega 3-EPA vs. DHA Fatty Acids in the Treatment of Major Depression
Depression, DNA Damage and Telomeres: A Chronic Stress Model of Accelerated Aging
Development of a Convenient, Automated, Objective Measure of Depression
Neuroanatomical abnormalities in binge drinking college students
Neural Correlates of Psychodynamic Psychotherapy for Depression
QEEG Predictors of Response for Psychotherapy Compared to Pharmacotherapy in Depression
Psychosocial treatment of Depressive disorders in Parkinson's Disease
Stress Reduction Intervention for Depressed Minority Patients
A three-phase study designed to test the efficacy, tolerability and safety of the combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI) Escitalopram for patients with Major Depressive Disorder (MDD) that do not sufficiently respond to treatment with Escitalopram
The Efficacy and Tolerability of Seroquel XR Combined with a Selective Serotonin Re-Uptake Inhibitor versus Seroquel XR Monotherapy in the Acute Treatment of Major Depressive Disorder with Psychotic Features
TRD-2; A Double-Blind, Placebo Controlled Study of 6(S)-5-MTHF (Deplin®) among SSRI-Resistant Outpatients with Major Depressive Disorder (MDD)
We initiate new studies regularly, so please contact us for additional information.
